RNIN vs. SMRI
RNIN (Bushido Capital US SMID Cap Equity ETF) and SMRI (Bushido Capital US Equity ETF) are both exchange-traded funds - RNIN is a Mid Cap Value Equities fund actively managed by Bushido, while SMRI is a Large Cap Value Equities fund actively managed by Bushido. Both are actively managed. Over the past year, RNIN returned 28.56% vs 35.67% for SMRI. Their correlation of 0.85 suggests significant overlap in exposure. RNIN charges 0.68%/yr vs 0.71%/yr for SMRI.
Performance
RNIN vs. SMRI - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, RNIN achieves a 15.93% return, which is significantly lower than SMRI's 18.58% return.
RNIN
- 1D
- -1.25%
- 1M
- 1.27%
- YTD
- 15.93%
- 6M
- 14.64%
- 1Y
- 28.56%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
SMRI
- 1D
- -0.15%
- 1M
- 11.41%
- YTD
- 18.58%
- 6M
- 18.82%
- 1Y
- 35.67%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
RNIN vs. SMRI - Yearly Performance Comparison
| 2026 (YTD) | 2025 | |
|---|---|---|
RNIN Bushido Capital US SMID Cap Equity ETF | 15.93% | 10.27% |
SMRI Bushido Capital US Equity ETF | 18.58% | 14.89% |
Correlation
The correlation between RNIN and SMRI is 0.84, indicating a strong positive relationship between their price movements. Combining them offers limited diversification - they tend to fall together during downturns.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.84 |
Correlation (All Time) Calculated using the full available price history since May 16, 2025 | 0.85 |
The correlation between RNIN and SMRI has been stable across timeframes, ranging from 0.84 to 0.85 - a consistent structural relationship.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
RNIN vs. SMRI — Risk / Return Rank
RNIN
SMRI
RNIN vs. SMRI - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Bushido Capital US SMID Cap Equity ETF (RNIN) and Bushido Capital US Equity ETF (SMRI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| RNIN | SMRI | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.93 | 2.46 | -0.53 |
Sortino ratioReturn per unit of downside risk | 2.82 | 3.53 | -0.71 |
Omega ratioGain probability vs. loss probability | 1.34 | 1.44 | -0.10 |
Calmar ratioReturn relative to maximum drawdown | 5.04 | 5.27 | -0.23 |
Martin ratioReturn relative to average drawdown | 17.82 | 16.62 | +1.20 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| RNIN | SMRI | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.93 | 2.46 | -0.53 |
Sharpe Ratio (All Time)Calculated using the full available price history | 1.78 | 1.44 | +0.33 |
Drawdowns
RNIN vs. SMRI - Drawdown Comparison
The maximum RNIN drawdown since its inception was -5.70%, smaller than the maximum SMRI drawdown of -18.45%. Use the drawdown chart below to compare losses from any high point for RNIN and SMRI.
Loading charts...
Drawdown Indicators
| RNIN | SMRI | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -5.70% | -18.45% | +12.75% |
Max Drawdown (1Y)Largest decline over 1 year | -5.70% | -6.80% | +1.10% |
Current DrawdownCurrent decline from peak | -2.55% | -1.17% | -1.38% |
Average DrawdownAverage peak-to-trough decline | -1.24% | -2.71% | +1.47% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 1.61% | 2.15% | -0.54% |
Volatility
RNIN vs. SMRI - Volatility Comparison
The current volatility for Bushido Capital US SMID Cap Equity ETF (RNIN) is 4.94%, while Bushido Capital US Equity ETF (SMRI) has a volatility of 5.42%. This indicates that RNIN experiences smaller price fluctuations and is considered to be less risky than SMRI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| RNIN | SMRI | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 4.94% | 5.42% | -0.48% |
Volatility (6M)Calculated over the trailing 6-month period | 10.50% | 10.94% | -0.44% |
Volatility (1Y)Calculated over the trailing 1-year period | 14.87% | 14.63% | +0.24% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 14.97% | 15.84% | -0.87% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 14.97% | 15.84% | -0.87% |
RNIN vs. SMRI - Expense Ratio Comparison
RNIN has a 0.68% expense ratio, which is lower than SMRI's 0.71% expense ratio.
Dividends
RNIN vs. SMRI - Dividend Comparison
RNIN's dividend yield for the trailing twelve months is around 0.76%, less than SMRI's 0.95% yield.
| Position | TTM | 2025 | 2024 | 2023 |
|---|---|---|---|---|
RNIN Bushido Capital US SMID Cap Equity ETF | 0.76% | 0.71% | 0.00% | 0.00% |
SMRI Bushido Capital US Equity ETF | 0.95% | 1.32% | 0.98% | 0.45% |
Frequently Asked Questions
RNIN and SMRI have a correlation of 0.84, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
SMRI has higher volatility (5.42%) compared to RNIN (4.94%). In terms of maximum drawdown, RNIN dropped -5.70% vs SMRI's -18.45%.
On 1-year performance, SMRI leads with 35.67% vs 28.56% for RNIN. On fees, RNIN is cheaper at 0.68% per year. On volatility, RNIN has been the lower-risk option at 4.94%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 1-year period, SMRI has performed better with a 35.67% return vs 28.56%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
RNIN is cheaper with a 0.68% expense ratio, compared with 0.71% for SMRI.
SMRI has the higher dividend yield at 0.95%, compared with 0.76% for RNIN.
RNIN is categorized as Mid Cap Value Equities, while SMRI is Large Cap Value Equities. Their fees differ too: 0.68% for RNIN and 0.71% for SMRI.
SMRI currently has the higher Sharpe Ratio (2.46 vs 1.93), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for RNIN and SMRI
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer